Published papers in peer-reviewed journals with scientific accomplishments of NANOM project:

1.   Kharlamov AN, Zubarev IV, Shishkina EV, Shur VY. Nanoparticles for treatment of atherosclerosis: Challenges of plasmonic photothermal therapy in translational studies. Future Cardiol. 2018;14(2).   doi:10.2217/fca-2017-0051
2.     Kharlamov AN, Feinstein JA, Cramer JA, Boothroyd JA, Shishkina EV, Shur V. Plasmonic photothermal therapy of atherosclerosis with nanoparticles: Long-term outcomes and safety in NANOM-FIM trial. Future Cardiol. 2017;13(4).
3.     Kharlamov AN, Tyurnina AE, Veselova VS, et al. Plasmonics for treatment of atherosclerosis: Results of NANOM-FIM trial. J Nanomedicine Nanotechnol. 2013;4(1). doi:10.4172/2157-7439.1000160
4.     Kharlamov AN, Tyurnina AE, Veselova VS, Kovtun OP, Shur VY, Gabinsky JL. Silica-gold nanoparticles for atheroprotective management of plaques: Results of the NANOM-FIM trial. Nanoscale. 2015;7(17):8003-8015.
5.     Kharlamov AN. Plasmonic photothermal therapy for atheroregression below Glagov threshold. Future Cardiol. 2013;9(3):405-425.
6.     Kharlamov AN, Gabinsky JL. Plasmonic photothermic and stem cell therapy of atherosclerotic plaque as a novel nanotool for angioplasty and artery
remodeling. Rejuvenation Res. 2012;15(2):222-230. doi:10.1089/rej.2011.1305
7.     Kharlamov AN, Gabinsky JL. Noble metal nanoparticles for plasmonic photothermal therapy of atherosclerosis. In: Technical Proceedings of the 2013 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2013. Vol
3. ;


Published papers in peer-reviewed journals with scientific accomplishments of ABSORB project: 


1. Kharlamov ANUndiscovered pathology of transient scaffolding remains a driver of failures in clinical trials. World J Cardiol. 2018 Oct 26;10(10):165-186. doi: 10.4330/wjc.v10.i10.165. PubMed PMID: 30386494; PubMed Central PMCID: PMC6205848
2.     Kharlamov AN, Feinstein JA, Cramer JA, Boothroyd JA. What exactly, regression of atherosclerosis or foreign body reaction with hyaline arteriosclerosis, drives transient scaffolding of coronary arteries? A pooled analysis of observational ABSORB studies with a serial multimodality imaging substudy of ABSORB. Int J Cardiol. 2016. doi:10.1016/j.ijcard.2017.05.134
3.     Kharlamov AN. Why do we fail to achieve Glagovian atheroregression in lipid-lowering trials? Interv Cardiol. 2015;7(5):469-482. doi:10.2217/ica.15.37
4.     Kharlamov AN. Scaffold thrombosis: Exaggerated illusion, or when statistics rules. Int J Cardiol. 2016;209:206-209. doi:10.1016/j.ijcard.2016.02.054
5.     Kharlamov AN. Can we adapt histological injury score for optical coherence tomography of coronaries? Int J Cardiol. 2013;168(4):4322-4324. doi:10.1016/j.ijcard.2013.04.168
6.     Muramatsu T, Onuma Y, Zhang Y-J, ... Kharlamov ANet al. Progress in treatment by percutaneous coronary intervention: The stent of the future | Avances en el tratamiento mediante intervención coronaria percutánea: el stent del futuro. Rev Esp Cardiol. 2013;66(6):483-496. doi:10.1016/j.recesp.2012.12.009
7.     Muramatsu T, Onuma Y, Zhang Y-J, ... Kharlamov ANet al. Progress in treatment by percutaneous coronary intervention: the stent of the future. Rev Esp Cardiol (Engl Ed). 2013;66(6):483-496. doi:10.1016/j.rec.2012.12.009
8.     Kharlamov AN. Bioresorbable scaffolds for atheroregression: Understanding of transient scaffolding. Curr Cardiol Rev. 2016;12(1):66-82.
9.     Kharlamov AN, Duckers HJ, Van Beusekom HMM, Smits PC, Perin EC, Serruys PW. Do we have a future with transcatheter adventitial delivery of stem cells? Int J Cardiol. 2013;165(2):217-221. doi:10.1016/j.ijcard.2012.11.063
10.     Lemos PA, Farooq V, Takimura CK, ... Kharlamov AN, et al. Emerging technologies: Polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention. 2013;9(1):146-156. doi:10.4244/EIJV9I1A21
11.     Kharlamov AN. Phenomenon of elongated struts: Is optical coherence tomography accurate enough to analyze scaffold area? Int J Cardiol. 2013;168(4):4280-4284. doi:10.1016/j.ijcard.2013.04.201
12.     Onuma Y, Muramatsu T, Kharlamov A, Serruys PW. Freeing the vessel from metallic cage: What can we achieve with bioresorbable vascular scaffolds? Cardiovasc Interv Ther. 2012;27(3):141-154. doi


Figure 4
Figure 4 (3)
Figure 2 (3)
Figure 2 (2)
Figure 3 (2)
Figure 2 (5)
Figure 2
Figure 3 (3)
Figure 4 (2)
Figure 3
Figure 1
Figure 1 (3)
Figure 2 (4)
Figure 1AB
Figure 1 (4)
Figure 1 (2)
Fig. 5A
Fig. 4
Fig. 6
Fig. 5B
Fig. 3
Fig 1
Fig. 2


CRT 2016
CRT 2016
CRT 2016
ESC 2018
ESC 2015
SCAI 2017
TCT 2016
TCT 2016
NN 2017
SCAI 2017
ESC 2015
ACC 2018
CIT 2017
EuroPCR 2017
CRT 2016




© 2023 by Actor & Model. Proudly created with